NCT00971867 - Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Head and Neck Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 4, 2006

Primary Completion Date

November 26, 2008

Study Completion Date

November 26, 2008

Conditions

Head and Neck Cancer

Interventions

DRUG

Paclitaxel

Solution, I.V., 100 mg/m2 Weekly for 6 of 7 weeks, Until disease progression or unacceptable toxicity became apparent

Trial Locations (9)

Local Institution, Meguro-ku

Local Institution, Kashiwa-shi

Local Institution, Sunto-gun

Local Institution, Osaka

Local Institution, Kagoshima

Local Institution, Matsuyama

Local Institution, Kanagawa

Local Institution, Yokohama

Local Institution, Tochigi